Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
US8088926B2 · kind B2 · utility
0Cited by
1References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2008 |
| Grant date | Jan 3, 2012 |
| Priority date | — |
| Expiry date | Jun 24, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel substituted 2-methyl-2-phenoxy-N-propyl-propionamides and derivatives thereof that are useful as cannabinoid receptor antagonists/inverse agonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, and/or cardiometabolic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.